Nano Theragnostics in Breast Cancer : Advances, Challenges, and Future Prospects, Belagodu Sridhar Sathvik,Husain Warsi Musarrat,Malviya Rishabha, Editör, Springer, Singapore, ss.1-34, 2025
Advanced breast cancer is marked by
a high metastatic profile and poor long-term survival rates. It is generally
more difficult to treat and has a worse prognosis. Metastasis to bone, liver,
lung, lung, brain and lymphatic system is seen in breast cancer. The breast
cancer microenvironment plays an important role affecting tumour growth, spread
and response to treatment. The breast cancer microenvironment refers to the
cellular, molecular, and vascular structures surrounding the tumor. In other
words, tumor cells are not composed solely of cancer cells; there are also
normal cells, fibroblasts , immune cells, lymphatic vessels, blood vessels
extracellular matrix (ECM), and other component parts around them. All of these
structures are referred to as the tumor microenvironment. Because of the
disruption of ECM morphology, the development of an immunosuppressive tumor
microenvironment facilitates proliferation and metastasis. The presence of this
microenvironment decreases the success rate of therapeutic methods such as
hormone therapy, immunotherapy, chemotherapy, and anti-angiogenic targeted
therapies. In this section, the components of the breast tumor
microenvironment; cancer cells, endothelial cells, immune cells,
cancer-associated fibroblasts, pericytes, and ECM will be discussed in detail.
The tumor microenvironment is a complicated environment that influences tumor
cell proliferation, cellular metabolism, vascularization, drug response, immune
cell response and metastasis pathways. To clarify this and intervene in the
microenvironment, it is essential to clarify the role of microenvironmental
components in breast cancer. This book chapter reviews microenvironmental
elements and briefly presents therapeutic approaches targeting the
immunomicroenvironment based on in preclinic and clinical phase studies.